Abdel Halim, PharmD, MSc, PhD, DABCC-MD, DABCC-CC, DABCC-Tox, FAACC
Founder and Chairman
Dr. Halim is a world class expert with 25+ years of experience in biomarkers and precision medicine. He led efforts to develop and qualify assays for hundreds of biomarkers on different technologies and utilized them for patient management and drug industry.
He has served as a key-opinion-leader on numerous governmental and public advisory boards and expert panels in the US, Canada and EU. He authored 70+ articles, 2 book chapters and full book, delivered 100+ presentations, and served on 20+ committees to develop clinical and laboratory guidelines improving laboratory medicine worldwide.
Abdel holds a Pharm D, two master degrees and a PhD in Cancer Molecular Biology, two post-doctoral fellowships and he is one of only four lab professionals in the USA who are triple board certified in Clinical Chemistry, Molecular Diagnostics, and Toxicology. Dr. Halim has served on multiple leadership positions in diagnostic, global pharma and biotech.
Founder and Chairman
Dr. Halim is a world class expert with 25+ years of experience in biomarkers and precision medicine. He led efforts to develop and qualify assays for hundreds of biomarkers on different technologies and utilized them for patient management and drug industry.
He has served as a key-opinion-leader on numerous governmental and public advisory boards and expert panels in the US, Canada and EU. He authored 70+ articles, 2 book chapters and full book, delivered 100+ presentations, and served on 20+ committees to develop clinical and laboratory guidelines improving laboratory medicine worldwide.
Abdel holds a Pharm D, two master degrees and a PhD in Cancer Molecular Biology, two post-doctoral fellowships and he is one of only four lab professionals in the USA who are triple board certified in Clinical Chemistry, Molecular Diagnostics, and Toxicology. Dr. Halim has served on multiple leadership positions in diagnostic, global pharma and biotech.